Monthly Archives: September 2015

FDA Adds a New AdComm for Patients

This week FDA published a Federal Register announcement stating that the agency was establishing a new Patient Engagement Advisory Committee designed to provide counsel to the Commissioner on issues related to medical devices. The agency said that the scope is … Continue reading

Posted in Advisory Committee Prepapartion, FDA Policy | Comments Off on FDA Adds a New AdComm for Patients

Weekly Roundup 9.18.15

For those of us hungry for it, we had our first taste of autumn. It has been lovely to sleep with windows open. Granted the long shadows appear earlier than they used to and the sun is setting from a … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 9.18.15

Then and Now – Shutdown Showdown

The last time we faced a government shut down, there were some advance communications on how various government agencies were going to be operating during the “event”. Last time, the executive brand had issued a memorandum on September 17, this … Continue reading

Posted in FDA Policy | Comments Off on Then and Now – Shutdown Showdown

Weekly Roundup 9.11.15

Today we remember those lost, honor those living who were there to help and dedicate ourselves to a goal of peace. Here is a bit of what happened this past week that I thought noteworthy: NIH Announces Landmark Blood Pressure … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 9.11.15

More on Twitter and Pharma

Before breaking for summer vacation, I had posted about the increase in Twitter followers among pharma companies this year over last and noted that the overall number of Twitter followers of pharma feeds had increase significantly. That was true despite … Continue reading

Posted in Social Media | Comments Off on More on Twitter and Pharma